Oct 10, 2017 09:29 AM IST |
Lupin gains 2% on USFDA approval for hypertension drug
The Nadolol tablets is a generic version of US WorldMeds, LLC Corgard Tablets, 20 mg, 40 mg and 80 mg.
Moneycontrol News
Shares of Lupin rose 2 percent intraday Tuesday on the back of USFDA approval for Nadolol tablets.
The company has received final approval for Nadolol Tablets USP 20 mg, 40 mg and 80 mg from the United States Food and Drug Administration (USFDA).
The Nadolol tablets is a generic version of US WorldMeds, LLC Corgard Tablets, 20 mg, 40 mg and 80 mg.
The tablets are indicated for management of patients with angina pectoris and for the treatment of hypertension.
According to IMS MAT June 2017 data, Nadolol tablets USP had annual sales of approximately USD 109.8 million in the US.
At 09:20 hrs Lupin was quoting at Rs 1,057.50, up Rs 17.70, or 1.70 percent.
Posted by Rakesh Patil
Stumps 
